Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galderma
Pharma
FDA approves Galderma's prurigo nodularis treatment Nemluvio
Swiss skincare specialist Galderma has earned FDA approval for Nemluvio to treat the debilitating and itchy skin disease prurigo nodularis.
Kevin Dunleavy
Aug 13, 2024 10:37am
Galderma kicks off the process for $2.6B IPO
Mar 13, 2024 12:17pm
Galderma tips 6 trends to shape aesthetics in '24 and beyond
Feb 8, 2024 7:59am
Galderma's liquid botulinum toxin bid nixed by FDA
Oct 3, 2023 11:14am
Galderma launches new breast cancer campaign
Oct 3, 2023 9:50am
Galderma raises $1B through private placement
Jun 27, 2023 11:02am
